Drug May Help Night-Shift Workers
WASHINGTON, Aug. 5 (UPI) — Working at night and sleeping during the day is not natural for…
February 20, 2023
WASHINGTON, Aug. 5 (UPI) — Working at night and sleeping during the day is not natural for…
Research to limit mental fatigue among soldiers may foster controversial ways to enhance any person’s brain Physicians…
A study by UC Davis researchers appearing in the journal Science on December 12, reports the discovery of a…
Attenace promising, Cephalon reports Cephalon Inc. has asked federal regulators to approve a version of its narcolepsy…
ABSTRACT OBJECTIVE: This study assessed the efficacy and safety of armodafinil, the longer half-life enantiomer of modafinil,…
ABSTRACT Hypocretin-1 (orexin-A) was administered to sleep-deprived (30–36 h) rhesus monkeys immediately preceding testing on a multi-image…
Dear Mr. Kirsch: This letter objects to Cephalon Inc’s (Cephalon) dissemination of false or misleading promotional materials1Â for…
ABSTRACT RATIONALE: In 1998, the FDA approved modafinil for treating excessive daytime sleepiness in narcoleptics, and this…
ABSTRACT The hypocretins (orexins) are a newly identified peptide family comprised of two peptides, hypocretin-1 and hypocretin-2….
ABSTRACT The effects of modafinil on glutamatergic and GABAergic transmission in the rat medial preoptic area (MPA)…